Diabetes

Type 2 Diabetes Types of Cancer Biomedical Research Experimental Drugs Research Studies Weight Management Chronic Conditions Public Health Funding Patient Care

3 ARTICLES

last wk.

Semaglutide Boosts Glycemic Control and Reduces Weight in Type 1 Diabetes Trial

Participants in the 26-week ADJUST-T1D trial experienced significant gains in target blood sugar range alongside substantial weight loss with weekly semaglutide.

4 ARTICLES

3w ago

FXYD2 Marker Enables Precise Selection of Mature Islets That Reverse Hyperglycemia in Diabetic Models

3 ARTICLES

4w ago

Experimental Drug Targets Hypoglycemia-Induced Retinal Damage in Diabetic Retinopathy

3 ARTICLES

2mo ago

First Human Trial of Type 1 Diabetes Immunotherapy Underway in Australia

4 ARTICLES

2mo ago

New Study Links Diabetes Drug Class to 45% Lower Dementia Risk

Diabetes

Semaglutide Boosts Glycemic Control and Reduces Weight in Type 1 Diabetes Trial

FXYD2 Marker Enables Precise Selection of Mature Islets That Reverse Hyperglycemia in Diabetic Models

Skin barrier test could reshape diabetic foot ulcer closure standards

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

Researchers Advance TYK2 Inhibitor Toward Type 1 Diabetes Clinical Trials

Experimental Drug Targets Hypoglycemia-Induced Retinal Damage in Diabetic Retinopathy

First Human Trial of Type 1 Diabetes Immunotherapy Underway in Australia

New Study Links Diabetes Drug Class to 45% Lower Dementia Risk